newsfilter
← Latest News
GlobeNewswire·

Bioasis Announces Filing of Its Fourth Quarter and Fiscal Year-End Financial Statements and MD&A

NEW HAVEN, Conn., June 14, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSXV:BTI, OTCQB:BIOAF), (the "Company" or "Bioasis"), a biopharmaceutical company developing its proprietary xB3 ™ platform technology for the delivery of therapeutics acr